Princeton, NJ & Amsterdam, NL – Christoph Krähenbühl, senior director, 3C Excellis, will be a featured speaker at Systech International’s upcoming global conference in Amsterdam titled UNIQUITY Europe, 2016, focused on serialization, global brand protection and consumer safety.

Krähenbühl is an expert on global serialization and tracing regulations. Serialization regulatory deadlines have either passed or are approaching in four of the top five pharmaceutical markets in the world with more being established each year.

With several EU countries planning new implementation requirements, manufacturers and packagers are required to implement unit-level traceability now, while still planning their migration to aggregation capability as the next phase of regulations become effective.

Krähenbühl has been involved in serialization Projects since 2006, lately as Product Security Manager at AstraZeneca, who were one of the early adopters and global leaders in pharma serialization.

“The pharmaceutical industry is facing a tremendous challenge to quickly comply with the European Medicines Agency’s (EMA) plans to implement packaging safety features as part of the Falsified Medicines Directive (Directive 2011/62/EU) (FMD), adopted in July of 2011,” explains Manfred Voglmaier, senior director, Europe, Systech International.

“Christoph speaks to the fact that they need to ramp up now if they are to meet the requirement for serialization of licensed drug products, which will be a legal requirement for companies in the EU starting in 2019.”

In 2012, Krähenbühl co-founded 3C Integrity with industry expert Ian Haynes, specializing in consulting and training in pharma serialization. In January of 2016, they combined with Excellis Health Solutions to form 3C Excellis Europe. 3C Excellis’ core business is to support pharma companies – brand owners, generic manufacturers, contract packers, from large enterprises operating world-wide to CMO and small specialized companies – in shaping up, planning and delivering their serialization programs.

“Christoph’s area of special expertise is the regulatory requirements landscape, particularly in Europe where he worked on the original EFPIA team that led to the EU-FMD requirements and is currently working for the EMVO (European Medicines Verification Organization) to support the engagement of the member states in the roll-out program,” said Voglmaier. “As such, he has an unparalleled understanding of global regulations and how to meet them using technology.”

A UNIQUITY Europe é uma conferência de dois dias que oferece as mais recentes percepções, recursos, ferramentas e oportunidades de networking para clientes, líderes do setor e fabricantes de equipamentos. O programa inclui palestrantes, apresentações, painéis de discussão e workshops sobre as melhores práticas e estratégias, além de treinamento prático e demonstrações de software de serialização e rastreamento.

Para obter mais informações ou para se registrar, visite https://www.systechone.com/uniquity2016eu/.

Sobre a Systech International
A Systech é líder global em tecnologia para segurança de produtos e proteção de marcas e consumidores. A Systech foi pioneira na serialização e está definindo o futuro da autenticação.

Com a confiança de 19 das 20 maiores empresas farmacêuticas, a Systech unifica e otimiza as tecnologias de serialização, rastreamento e autenticação empresariais para garantir a conformidade regulamentar, reduzir os riscos e aumentar a eficiência e a lucratividade.

Durante 30 anos, a inovação da Systech liderou as melhores práticas para as principais marcas dos setores farmacêutico, de ciências biológicas, de alimentos e bebidas e de bens de consumo embalados.

Contato:
Ann Willets
Representante de Relações Públicas da Systech International
(908) 433 7821
aw@26FIVE.com